Shaping services

Our CAMHS transformation plan was shaped by young people in Newham.

Our CAMHS transformation plan was shaped by young people in Newham

Over the past four years, we have made significant progress in working alongside patients, the public and other health and social care providers to develop high quality services that best meet the needs of our local communities. 

Newham is a challenging borough for Patient and Public Engagement (PPE). Its hugely diverse population speaks over one hundred different languages and is highly transient - 20% of Newham’s population moves in or out of the borough every year. It is also a very young area. At the time of the 2011 census, it had the youngest population of any borough in the country.  

Newham’s health situation too is far from straightforward. It has, for example, the highest birth rate in the country, above average rates of conditions such as obesity and diabetes, and significant numbers of local residents who suffer from mental ill health.  

Against this backdrop, we have always believed that PPE is part of the solution to the borough’s health issues. We created a number of permanent PPE structures and contracted out their delivery to a local third sector organisation. More recently, we have also begun to design and deliver tailored engagement activities in-house.  

You can find out more about our work by following the tabs to the left, as well as in our Annual Report and in About Us. You can also attend a meeting of our Governing Body

Guidance from NHS England on medicines of limited clinical effectiveness

Following an extensive consultation, NHS England have identified a number of medicines that should not be routinely prescribed due to their limited effectiveness.

This national guidance will  ensure people receive the safest and most effective treatment available, and save the NHS up to £141 million a year.  The  medicines fall  into one or more of the following categories:

  • Products of low clinical effectiveness, where there is a lack of robust evidence of clinical effectiveness or there are significant safety concerns;
  • Products which are clinically effective but where more cost effective products are available, including some products that have been subject to excessive price inflation; and
  • Products which are clinically effective but due to the nature of the product are deemed a low priority for NHS funding.

The list of medications are as follows:

  • Co-proxamol
  • Dosulepin
  • Doxazosin MR
  • Fentanyl IR
  • Glucosamine and Chondroitin
  • Herbal supplements
  • Homeopathy
  • Lidocaine plasters
  • Liothyronine  
  • Lutein and antioxidants
  • Omega3 fatty acids
  • Oxycodone and naloxone combination
  • Paracetamol and tramadol combination
  • Perindopril arginine
  • Rubifacients 
  • Tadalafil once daily
  • Trimipramine  

Seven additional medicines were included after further consultation:

  • Aliskerin
  • Amiodarone
  • Bath and shower preparations
  • Dronedarone
  • Minocycline
  • Needles for pre-filled and reusable insulin pens
  • Silk garments

Your doctor will exercise their clinical judgement when making decisions.